Concepedia

Publication | Closed Access

Risk of severe COVID‐19 in patients treated with IBD medications: a French nationwide study

DOI

36

Citations

12

References

2021

Year

Antoine Meyer, Laura Semenzato, Mahmoud Zureik, Alain Weill, Franck Carbonnel, Rosemary Dray‐Spira
Alimentary Pharmacology & Therapeutics

Abstract

Immunomodulators and biologics prescribed in patients with IBD do not appear to increase the severity of COVID-19 infection.

References

YearCitations

Page 1